Biotechnology, people and markets

New Genetics and Society

Volumn 21, Issue 2, 2002, Pages 199-212

  Green, Ken ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; MARKET; PRIORITY JOURNAL; PUBLIC OPINION; REVIEW; SOCIOLOGY; UNITED KINGDOM;

EID: 0036695436     PISSN: 14636778     EISSN: None     Source Type: Journal    
DOI: 10.1080/1463677022000007014     Document Type: Review

References (54)

1. Beck, U. (1992) The Risk Society: Towards a New Modernity (London: Sage).
2. Bereano, P. & Kraus, F. (1999) The politics of genetically engineered food: the US vs. Europe, available at the website of the US Loka Institute (www.loka.org).
3. Bergham, J. (1995) Social exclusion in Europe: policy context and analytical framework. In Room, G. (ed.) Beyond the Threshold: The Measurement and Analysis of Social Exclusion (Bristol: Policy Press).
4. Bijker, W. & Law, J. (eds) (1992) Shaping Technology/Building Society: Studies in Sociotechnical Change (Cambridge, MA: MIT Press).
5. Bijker, W., Hughes, T. & Pinch, T. (eds) (1987) The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology (Cambridge, MA: MIT Press).
6. Billings, P.R. (1999) In utero gene therapy: the case against, Nature Medicine, 5, pp. 255-6.
7. Birke, L. & Michael, M. (1998) The heart of the matter: animal bodies, ethics and species boundaries, Society and Animals, 6, pp. 245-61.
8. Bloomfield, B. (1999) Care of the self: the confluence of diagnostic genetic therapy and new reproductive technologies in the context of insurance, paper presented to workshop on New Health Technologies and Future Oriented Co-ordination: The Role of Expectations in Medical Innovations, University of Twente, Netherlands, September.
9. Callon, M., Law, J. & Rip, A. (1986) Mapping the Dynamics of Science and Technology: Sociology of Science in the Real World (London: Macmillan).
10. Daemmrich, A. (1998) The evidence does not speak for itself: expert witnesses and the organisation of DNA-typing companies, Social Studies of Science, 28, pp. 741-72.
11. Deuten, J.J., Rip, A. & Jelsma, J. (1997) Societal embedding and product creation management, Technology Analysis and Strategic Management, 9, pp. 131-48.
12. Dosi, G. (1982) Technological paradigms and technological trajectories, Research Policy, 11, pp. 147-62.
13. ESRC (1999) The Politics of GM Food: Risk, Science and Public Trust, Special Briefing No. 5 (Brighton: University of Sussex).
14. Fano, A. (2001) If Pigs could fly, they would: the problems with xenotransplantation. In Tokar, B. (ed.) Redesigning Life? The Worldwide Challenge to Genetic Engineering (London: Zed Books).
15. Franks, J.R. (1999) The status and prospects for genetically-modified crops in Europe, Food Policy, 25, pp. 565-84.
16. Fuller, B.P. et al. (1999) Privacy in genetics research, Science, 285 (5432), pp. 1359-61.
17. Gordon, J.W. (1999) Genetic enhancement in humans, Science, 283 (5410), pp. 2023-4.
18. Green, K. (1991) Shaping technology and shaping markets: creating demand for biotechnology, Technology Assessment and Strategic Management, 3, pp. 57-76.
19. Green, K. & Hyde, B. (1990) Near-patient Testing: Health Policy Implications of New Diagnostic Technologies (Manchester: Manchester School of Management, University of Manchester Institute of Science and Technology).
20. Grove-White, R., Macnaghten, P., Mayer, S. & Wynne, B. (1997) Uncertain World: Genetically Modified Organisms, Food and Public Attitudes in Britain (Lancaster: Lancaster University).
21. Harris, J. (1998) Clones, Genes and Immortality: Ethics and the Genetic Revolution (Oxford, Oxford University Press).
22. Harvey, M. (1999) Cultivation and comprehension: how genetic modification irreversibly alters the human engagement with nature, Sociological Research Online, 4 (http://www.surrey.ac.uk/ socresonline/).
23. Harvey, M. (2000) The Formation of a Genetically Modified Food and its Markets: The GM Tomato in the UK (Manchester: Centre for Research on Innovation and Competition).
24. Hudson, K.L., Rothenberg, K.H., Andrews, L.B., Ellis Kahn, M.J. & Collins, F.S. (1995) Genetic discrimination and health insurance: an urgent need for reform, Science, 270 (5235), pp. 391-3.
25. Hughes, P.H. (1983) Networks of Power: Electrification in Western Society, 1890-1930 (Baltimore, MD: Johns Hopkins University Press).
26. Irwin, A. (1985) Risk and the Control of Technology (Manchester: Manchester University Press).
27. Irwin, A. (1995) Citizen Science: A Study of People, Expertise and Sustainable Development (London: Routledge).
28. Jacobs, R. (1997) Genetic screening - uses, potential abuses and ethical issues, Occupational Medicine, 47, pp. 367-70.
29. Joly, P.-B. (1999) Innovating through networks: a case study in plant biotechnology, International Journal of Biotechnology, 1, pp. 67-81.
30. Kammen, J. van (1999) Users' involvement in contraceptive innovation: the design of anti-fertility vaccines, paper presented at the Fifth ASEAT (Advances in Sociological and Economic Analysis of Technology) Conference on Demand, Markets, Users and Innovation: Sociological and Economic Approaches, Manchester, September.
31. Knoppers, B.M. (1999) Status, sale and patenting of human genetic material: an international survey, Nature Genetics, 22, pp. 23-6.
32. Koechlin, D. & Wittke, A. (1998) Sustainable business and the pesticide business: a comparison. In Vorley, W. & Keeney, D. (eds) Bugs in the System: Redesigning the Pesticide Industry for Sustainable Agriculture (London: Earthscan).
33. Koh, D. & Jeyaratnam, J. (1998) Biomarkets, screening and ethics, Occupational Medicine, 48, pp. 27-30.
34. Lappe, M. & Bailey, B. (1999) Against the Grain: The Genetic Transformation of Global Agriculture (London: Earthscan).
35. Latour, B. (1988) The prince for machines as well as for machinations. In Elliott, B. (ed.) Technology and Social Process (Edinburgh: Edinburgh University Press).
36. Levidow, L., Carr, S., Wield, D. & Schomberg, R. von (1997) European biotechnology regulation: framing the risk assessment of herbicide-tolerant crops, Science, Technology and Human Values, 22, pp. 472-505.
37. MacKenzie, D. & Wajcman, J. (1999) The Social Shaping of Technology, 2nd edition (Buckingham: Open University Press).
38. Martin, P. (2001) Great expectations: the construction of markets, products and user needs during the early development of gene therapy in the USA. In Coombs, R., Green, K., Richards, A. & Walsh, V. (eds) Technology and the Market: Demand Users and Innovation (Cheltenham: Edward Elgar).
39. McKinnell, R.G. & Di Bernardino, M.A. (1999) The biology of cloning: history and rationale, Bioscience, 49, pp. 875-85.
40. Motulsky, A.G. (1999) If I had a gene test, what would I have and who would I tell?, Lancet, July, pp. 35-7.
41. Nelkin, D. & Tancredi, L. (1994) Dangerous Diagnostics: The Social Power of Biological Information (Chicago, IL: University of Chicago Press).
42. New Internationalist (1997) Issue on 'gene dream', 293, August.
43. Nottingham, S. (1998) Eat Your Genes: How Genetically Modified Food is Entering Our Diet (London: Zed Books)
44. Powell, W.W. (1999) The social construction of an organizational field: the case of biotechnology, International Journal of Biotechnology, 1, pp. 42-66.
45. Rifkin, J. (1998) The Biotech Century (New York: Penguin Puttnam).
46. Rissler, J. & Mellon, M. (1996) The Ecological Risks of Engineered Crops (Cambridge, MA: MIT Press).
47. Rose, D.A. (2001) Reconceptualising the user(s) of - and in - technological innovation: the case of vaccines in the USA. In Coombs, R., Green, K., Richards, A. & Walsh, V. (eds) Technology and the Market: Demand Users and Innovation (Cheltenham: Edward Elgar).
48. Rothenberg, K. et al. (1997) Genetic information and the workplace: legislative approaches and policy challenges, Science, 275 (5037), pp. 1755-7.
49. Royal Association for Disability and Rehabilitation (1999) Genes Are Us.
50. Satris, S. (1998) Ethical issues in cloning, Critical Reviews in Biomedical Engineering, 26, p. 384.
51. Stirling, A. & Mayer, S. (1999) Rethinking Risk: A Pilot Multi-criteria Mapping of a Genetically-modified Crop in Agricultural Systems in the UK (Brighton: Science Policy Research Unit).
52. Williams, R. & Edge, D. (1996) The social shaping of technology, Research Policy, 25, pp. 865-99.
53. Wootton, R. (1999) The commercialisation of GM crops: an actor-world approach, unpublished MSc dissertation, Manchester School of Management, University of Manchester Institute of Science and Technology.
54. Yoxen, E. & Green, K. (1990) Scenarios for Biotechnology in Europe: A Research Agenda (Dublin: European Foundation for the Improvement of Living and Working Conditions).